Atlas Trials

Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic Pathways

Clinical trial NCT05124288 · RECRUITING

Trial details

NCT number
NCT05124288
Sponsor
Ciceri Fabio
Status
RECRUITING
Study type
OBSERVATIONAL
Acute Myeloid Leukemia, in Relapse
Start date
2022-07-18
Primary completion
2026-12-20
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.